These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12482779)

  • 1. Assessment of myocardial viability: using coronary pressure and flow after acute myocardial infarction.
    Kern MJ
    Heart; 2003 Jan; 89(1):9-10. PubMed ID: 12482779
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction.
    Shimada K; Sakanoue Y; Kobayashi Y; Ehara S; Hirose M; Nakamura Y; Fukuda D; Yamagishi H; Yoshiyama M; Takeuchi K; Yoshikawa J
    Heart; 2003 Jan; 89(1):71-6. PubMed ID: 12482796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose metabolism in myocardium and an assessment of myocardial viability by 18FDG-PET].
    Ogiu N; Nakai K; Hiramori K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):636-40. PubMed ID: 12436594
    [No Abstract]   [Full Text] [Related]  

  • 4. Reverse flow-metabolism mismatch: what does it mean?
    Schwaiger M; Pirich C
    J Nucl Med; 1999 Sep; 40(9):1499-502. PubMed ID: 10492371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery flow velocity profile measured by transthoracic Doppler echocardiography predicts myocardial viability after acute myocardial infarction.
    Saraste A; Koskenvuo JW; Saraste M; Pärkkä J; Toikka J; Naum A; Ukkonen H; Knuuti J; Airaksinen J; Hartiala J
    Heart; 2007 Apr; 93(4):456-7. PubMed ID: 17135221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of positron emission tomography in cardiology: a review.
    Keng FY
    Ann Acad Med Singap; 2004 Mar; 33(2):175-82. PubMed ID: 15098630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of left ventricular volume and ejection on myocardial blood flow measured by oxygen-15 water positron emission tomography in coronary heart disease.
    Schaefer WM; Koch KC; Kuhl HP; Reinartz P; Kaiser HJ; vom Dahl J; Sabri O; Buell U; Nowak B
    Am J Cardiol; 2003 Feb; 91(4):469-72. PubMed ID: 12586270
    [No Abstract]   [Full Text] [Related]  

  • 10. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Med; 1999 Sep; 40(9):1492-8. PubMed ID: 10492370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-deoxyglucose and the assessment of myocardial viability.
    Schelbert HR
    Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of myocardial viability by positron emission tomography].
    Jiménez-Hoyuela JM; Alavi A; Araujo LI
    Rev Esp Med Nucl; 1998; 17(1):49-60. PubMed ID: 9609845
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of myocardial viability in deriving benefit from reestablishing infarct-related artery flow after acute myocardial infarction.
    Anselmi M; Bolognese L; Chierchia S; Maggioni A; Marino P
    Prog Cardiovasc Dis; 2000; 42(6):455-70. PubMed ID: 10871166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
    Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
    J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions.
    Nakano A; Lee JD; Shimizu H; Yonekura Y; Ueda T
    J Nucl Cardiol; 2000; 7(5):454-60. PubMed ID: 11083194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization.
    Schmidt M; Voth E; Schneider CA; Theissen P; Wagner R; Baer FM; Schicha H
    Magn Reson Imaging; 2004 Feb; 22(2):229-36. PubMed ID: 15010115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thallium scintigraphy and positron emission tomography.
    Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE
    Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does chronic ST segment elevation following Q wave myocardial infarction exclude tissue viability?
    Saber W; Nishime EO; Brunken RC; Apperson-Hansen C; Mills RM
    Cardiology; 2003; 100(1):11-6. PubMed ID: 12975540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.